337 related articles for article (PubMed ID: 25683354)
1. Comparative Analysis of Different Methods of Ischemia/Reperfusion in Hyperglycemic Stroke Outcomes: Interaction with tPA.
Hafez S; Hoda MN; Guo X; Johnson MH; Fagan SC; Ergul A
Transl Stroke Res; 2015 Jun; 6(3):171-80. PubMed ID: 25683354
[TBL] [Abstract][Full Text] [Related]
2. Transient brain hypothermia reduces the reperfusion injury of delayed tissue plasminogen activator and extends its therapeutic time window in a focal embolic stroke model.
Zarisfi M; Allahtavakoli F; Hassanipour M; Khaksari M; Rezazadeh H; Allahtavakoli M; Taghavi MM
Brain Res Bull; 2017 Sep; 134():85-90. PubMed ID: 28710023
[TBL] [Abstract][Full Text] [Related]
3. Effects of tissue plasminogen activator timing on blood-brain barrier permeability and hemorrhagic transformation in rats with transient ischemic stroke.
Zhang Y; Wang Y; Zuo Z; Wang Z; Roy J; Hou Q; Tong E; Hoffmann A; Sperberg E; Bredno J; Berr SS; Xie M; Lee K; Wintermark M
J Neurol Sci; 2014 Dec; 347(1-2):148-54. PubMed ID: 25292413
[TBL] [Abstract][Full Text] [Related]
4. Acute Hyperglycemia Exacerbates Hemorrhagic Transformation after Embolic Stroke and Reperfusion with tPA: A Possible Role of TXNIP-NLRP3 Inflammasome.
Salman M; Ismael S; Li L; Ahmed HA; Puchowicz MA; Ishrat T
J Stroke Cerebrovasc Dis; 2022 Feb; 31(2):106226. PubMed ID: 34847489
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of the neurovascular injury and functional outcomes in experimental stroke models in diabetic Goto-Kakizaki rats.
Li W; Qu Z; Prakash R; Chung C; Ma H; Hoda MN; Fagan SC; Ergul A
Brain Res; 2013 Dec; 1541():106-14. PubMed ID: 24144674
[TBL] [Abstract][Full Text] [Related]
6. Whole body hypothermia extends tissue plasminogen activator treatment window in the rat model of embolic stroke.
Hassanipour M; Zarisfi M; Ehsani V; Allahtavakoli M
Life Sci; 2020 Sep; 256():117450. PubMed ID: 32087233
[TBL] [Abstract][Full Text] [Related]
7. Peroxynitrite-Induced Tyrosine Nitration Contributes to Matrix Metalloprotease-3 Activation: Relevance to Hyperglycemic Ischemic Brain Injury and Tissue Plasminogen Activator.
Hafez S; Abdelsaid M; Fagan SC; Ergul A
Neurochem Res; 2018 Feb; 43(2):259-266. PubMed ID: 28975464
[TBL] [Abstract][Full Text] [Related]
8. IMM-H004 prevents toxicity induced by delayed treatment of tPA in a rat model of focal cerebral ischemia involving PKA-and PI3K-dependent Akt activation.
Zuo W; Chen J; Zhang S; Tang J; Liu H; Zhang D; Chen N
Eur J Neurosci; 2014 Jun; 39(12):2107-18. PubMed ID: 24649933
[TBL] [Abstract][Full Text] [Related]
9. THR-18, a 18-mer peptide derived from PAI-1, is neuroprotective and improves thrombolysis by tPA in rat stroke models.
Krakovsky M; Polianski V; Nimrod A; Higazi A; Leker RR; Lamensdorf I
Neurol Res; 2011 Nov; 33(9):983-90. PubMed ID: 22081002
[TBL] [Abstract][Full Text] [Related]
10. Combined tissue plasminogen activator and an NK1 tachykinin receptor antagonist: an effective treatment for reperfusion injury following acute ischemic stroke in rats.
Turner RJ; Vink R
Neuroscience; 2012 Sep; 220():1-10. PubMed ID: 22750240
[TBL] [Abstract][Full Text] [Related]
11. Hyperglycemia, acute ischemic stroke, and thrombolytic therapy.
Hafez S; Coucha M; Bruno A; Fagan SC; Ergul A
Transl Stroke Res; 2014 Aug; 5(4):442-453. PubMed ID: 24619488
[TBL] [Abstract][Full Text] [Related]
12. Effects of admission hyperglycemia on stroke outcome in reperfused tissue plasminogen activator--treated patients.
Alvarez-Sabín J; Molina CA; Montaner J; Arenillas JF; Huertas R; Ribo M; Codina A; Quintana M
Stroke; 2003 May; 34(5):1235-41. PubMed ID: 12677014
[TBL] [Abstract][Full Text] [Related]
13. Reduction of tissue plasminogen activator-induced hemorrhage and brain injury by free radical spin trapping after embolic focal cerebral ischemia in rats.
Asahi M; Asahi K; Wang X; Lo EH
J Cereb Blood Flow Metab; 2000 Mar; 20(3):452-7. PubMed ID: 10724108
[TBL] [Abstract][Full Text] [Related]
14. Ascorbic Acid Reduces the Adverse Effects of Delayed Administration of Tissue Plasminogen Activator in a Rat Stroke Model.
Allahtavakoli M; Amin F; Esmaeeli-Nadimi A; Shamsizadeh A; Kazemi-Arababadi M; Kennedy D
Basic Clin Pharmacol Toxicol; 2015 Nov; 117(5):335-9. PubMed ID: 25899606
[TBL] [Abstract][Full Text] [Related]
15. Toll-Like Receptor 4 Mediates Hemorrhagic Transformation After Delayed Tissue Plasminogen Activator Administration in In Situ Thromboembolic Stroke.
García-Culebras A; Palma-Tortosa S; Moraga A; García-Yébenes I; Durán-Laforet V; Cuartero MI; de la Parra J; Barrios-Muñoz AL; Díaz-Guzmán J; Pradillo JM; Moro MA; Lizasoain I
Stroke; 2017 Jun; 48(6):1695-1699. PubMed ID: 28428349
[TBL] [Abstract][Full Text] [Related]
16. Hyperglycemia during ischemia rapidly accelerates brain damage in stroke patients treated with tPA.
Ribo M; Molina CA; Delgado P; Rubiera M; Delgado-Mederos R; Rovira A; Munuera J; Alvarez-Sabin J
J Cereb Blood Flow Metab; 2007 Sep; 27(9):1616-22. PubMed ID: 17299452
[TBL] [Abstract][Full Text] [Related]
17. Intravenous administration of a GPIIb/IIIa receptor antagonist extends the therapeutic window of intra-arterial tenecteplase-tissue plasminogen activator in a rat stroke model.
Zhang L; Zhang ZG; Zhang C; Zhang RL; Chopp M
Stroke; 2004 Dec; 35(12):2890-5. PubMed ID: 15514182
[TBL] [Abstract][Full Text] [Related]
18. Endogenous tissue plasminogen activator increases hemorrhagic transformation induced by heparin after ischemia reperfusion in rat brains.
Tang J; Li YJ; Li Q; Mu J; Yang DY; Xie P
Neurol Res; 2010 Jun; 32(5):541-6. PubMed ID: 19309545
[TBL] [Abstract][Full Text] [Related]
19. tPA Mobilizes Immune Cells That Exacerbate Hemorrhagic Transformation in Stroke.
Shi K; Zou M; Jia DM; Shi S; Yang X; Liu Q; Dong JF; Sheth KN; Wang X; Shi FD
Circ Res; 2021 Jan; 128(1):62-75. PubMed ID: 33070717
[TBL] [Abstract][Full Text] [Related]
20. Opening the window: Ischemic postconditioning reduces the hyperemic response of delayed tissue plasminogen activator and extends its therapeutic time window in an embolic stroke model.
Esmaeeli-Nadimi A; Kennedy D; Allahtavakoli M
Eur J Pharmacol; 2015 Oct; 764():55-62. PubMed ID: 26123846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]